Clinical Trials Logo
  1. Home
  2. Panic Attack
  3. NCT01944423

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine — DCS/PSRT  

Nicotine Addiction Clinical Trial

Official title:
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

Clinical Trial Summary

The purpose of the current study is to evaluate the efficacy of d-cycloserine in augmenting treatment of smoking cessation for individuals with panic attacks. The investigators hypothesize that individuals receiving DCS (versus those receiving placebo) will evidence greater smoking abstinence rates and decreased panic symptoms after receiving a combined CBT-based treatment for smokers with panic attacks.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01944423
Study type Interventional
Source University of Texas at Austin
Contact
Status Completed
Phase Early Phase 1
Start date October 2013
Completion date October 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Completed NCT02153749 - Effects of Brief Training on Craving Regulation N/A
Recruiting NCT05530577 - Effects of Semaglutide on Nicotine Intake Phase 2
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT01704573 - Nicotinic Receptor Levels After Stopping Smoking N/A
Active, not recruiting NCT01015170 - STOP Study: Effectiveness of Zyban in a Clinical Population Phase 4
Completed NCT03281629 - Circuitry-Guided Smoking Cessation in Schizophrenia N/A
Recruiting NCT06291584 - Effects of Exercises on Functional Capacity N/A
Withdrawn NCT06259630 - Nicotine Virtual Reality Conditioned Place Preference Phase 4
Completed NCT02624284 - tDCS Effects on Resisting Smoking: Dose Ranging Study N/A
Active, not recruiting NCT02837510 - Neural Mechanisms Associated With Risk of Smoking Relapse N/A
Completed NCT02656745 - Clinical Trial of Smoking Cessation Mobile Phone Program N/A
Completed NCT01062932 - Investigation of Cycloserine as a Smoking Cessation Treatment Phase 1
Completed NCT03069482 - Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Phase 1
Completed NCT02870218 - Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use Phase 2
Terminated NCT01756053 - Effects of ABT-089 on Smoking Abstinence Symptoms and Reward Phase 2
Completed NCT01252966 - Cognitive Training for Nicotine Dependence N/A
Active, not recruiting NCT04946825 - Quit Smoking Study for People Who Use E-Cigarettes Phase 2
Recruiting NCT05434429 - Mobile Health for Problematic Behaviors and Substance Use N/A